InvestorsHub Logo
Followers 86
Posts 12714
Boards Moderated 0
Alias Born 10/12/2010

Re: jakedogman1 post# 142558

Friday, 09/27/2013 10:26:39 AM

Friday, September 27, 2013 10:26:39 AM

Post# of 346050
Jakedogman1.... do you think there is a connection between Adam Feuerstein and Bristol Meyers Squibb? It doesn't have to be a "direct" connection "solely" to BMS, but rather I should say is "suggested" to what to write? A biotech writer likes a story the biggest biotech story of the century is similar to what the Catholic Church went thru in its early stages when everyone knew what was happening but turned a blind eye. Its only a matter of time for Peregrine to move into a new class, because all it takes is one BP that wants to stay in this game for the longterm. As for AF...

"Bavituximab is a first-in-class phosphatidylserine (PS)-targeting monoclonal antibody that is the cornerstone of a broad clinical
pipeline."
-- Big Pharmas nightmare... unless they are fortunate enough to have The Bavi Edge!

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News